|
Market Closed -
OTC Markets
15:21:53 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 0.0909 USD | -6.91% |
|
-5.20% | -43.92% |
| 08-19 | Avicanna Inc. announced that it has received CAD 0.5 million in funding | CI |
| 08-19 | Avicanna Closes C$500,000 Private Placement to Pharmaceutical Investor Michael Porter | MT |
Company Valuation: Avicanna Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 49.1 | 35.79 | 30.73 | 31.74 | 33.62 | 26.56 |
| Change | - | -27.12% | -14.14% | 3.27% | 5.92% | -20.99% |
| Enterprise Value (EV) 1 | 48.53 | 37.42 | 32.75 | 33.06 | 33.28 | 26.28 |
| Change | - | -22.88% | -12.49% | 0.97% | 0.65% | -21.03% |
| P/E | -1.17x | -1.92x | -1.65x | -3.39x | -8.43x | -9.36x |
| PBR | 7.81x | 31.2x | -80.1x | -282x | 14.5x | 9.34x |
| PEG | - | 0x | 0x | 0.1x | 0.1x | 0.3x |
| Capitalization / Revenue | 31.3x | 10.9x | 7.59x | 1.89x | 1.32x | 1.04x |
| EV / Revenue | 30.9x | 11.4x | 8.09x | 1.97x | 1.31x | 1.03x |
| EV / EBITDA | -2.77x | -3.45x | -3.34x | -4.2x | -8.04x | -11.7x |
| EV / EBIT | -2.66x | -3.28x | -3.15x | -3.95x | -7.11x | -9.44x |
| EV / FCF | -6.9x | -4x | -4.97x | -8.46x | -18.1x | -47.4x |
| FCF Yield | -14.5% | -25% | -20.1% | -11.8% | -5.51% | -2.11% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.118 | -0.4063 | -0.249 | -0.1032 | -0.0362 | -0.0241 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1.57 | 3.269 | 4.048 | 16.79 | 25.46 | 25.48 |
| EBITDA 1 | -17.49 | -10.85 | -9.812 | -7.871 | -4.138 | -2.243 |
| EBIT 1 | -18.27 | -11.41 | -10.41 | -8.38 | -4.68 | -2.782 |
| Net income 1 | -32.86 | -16.77 | -14.74 | -8.743 | -3.618 | -2.759 |
| Net Debt 1 | -0.5788 | 1.631 | 2.016 | 1.326 | -0.3388 | -0.2806 |
| Reference price 2 | 1.3100 | 0.7800 | 0.4100 | 0.3500 | 0.3050 | 0.2250 |
| Nbr of stocks (in thousands) | 37,485 | 45,884 | 74,953 | 90,677 | 110,215 | 118,042 |
| Announcement Date | 9/3/21 | 3/31/22 | 3/31/23 | 4/2/24 | 4/11/25 | 4/1/26 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.52x | 6.15x | 18.3x | 0.93% | 50.96B | |
| -22.19x | 290.43x | -23.05x | -.--% | 46.18B | |
| 49.23x | 5.72x | 31.29x | -.--% | 42.73B | |
| 33.68x | 3.27x | 14.09x | -.--% | 43.04B | |
| 29.37x | 8.87x | 22.41x | 0.39% | 33.48B | |
| 35.2x | 5.78x | 26.25x | -.--% | 17.28B | |
| 24.28x | 2.11x | 9.12x | 1.11% | 14.73B | |
| 78.94x | 4.14x | 16.07x | -.--% | 14.09B | |
| Average | 32.88x | 40.81x | 14.31x | 0.3% | 32.81B | |
| Weighted average by Cap. | 28.00x | 55.61x | 12.86x | 0.29% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AVCN Stock
- AVCNF Stock
- Valuation Avicanna Inc.
Select your edition
All financial news and data tailored to specific country editions
